Halozyme Therapeutics, Inc. announced the appointment of Moni Miyashita to its board of directors. Ms. Miyashita is an accomplished executive with over 25 years of global strategic, mergers & acquisitions and business transformation expertise.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
51.42 USD | +1.11% | +13.78% | +38.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.69% | 647.19Cr | |
+18.99% | 12TCr | |
+13.96% | 11TCr | |
-7.54% | 2.42TCr | |
+2.07% | 2.28TCr | |
-10.79% | 1.8TCr | |
-41.74% | 1.64TCr | |
-13.94% | 1.64TCr | |
+2.47% | 1.36TCr | |
+28.48% | 1.17TCr |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Halozyme Therapeutics, Inc. Appoints Moni Miyashita to Board of Directors